DEBRA Australia is pleased to call for applications for new research funding for projects aimed at improving the health and wellbeing of children and adults with Epidermolysis Bullosa (EB), in any of DEBRA’s priority research areas. The deadline for application submission is 31 October  2016. Two grants of up to AUD $30,000 each  are being offered. It is planned that decisions on funding applications from this call will be made in December 2016. Projects may be laboratory based, a clinical study, or a combination. Projects are expected to start in January 2017 and be  finished by December 2017. Please review the attached guidelines carefully before completing your application.

Applicants are strongly encouraged to study these guidelines, terms and conditions carefully before preparing their application.

DEBRA’s Research Priorities are:

  • Development of therapies, including possible gene-therapies, cell-therapies, drug therapies or protein therapies;
  • Wound healing and skin cancer in EB;
  • Clinical research to improve management of EB.
  • Biology and genetics of all forms of EB, where it can be shown that this may help lead to new approaches to treat EB.

For full terms and conditions: DEBRA Australia 2016 Research Grant Application Guidelines, Terms and Conditions

Apply Now

To apply, download the PDF file of the Grant Application form and complete (electronically or in black ink), print one (1) FULL copy along with any supporting documentation, and mail to DEBRA Australia, PO Box 226, PITTSWORTH, QLD, 4356 and email one electronic copy in PDF format to secretary@debra.org.au.